Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

The FDA believed that Prandin was a very innovative drug that would provide the fast growing number of Americans suffering from type II diabetes with a better and more convenient treatment for their health problems. For this reason, the FDA was willing to put Prandin application on the fast track which would allow Novo Nordisk to have the product registered (thus making it legal to sell) in a maximum of 6 months. The decision to schedule the initial worldwide launch of Prandin / Novonorm in the United States in an extremely short time frame was not easy at all.
Location:
Industry:
Other setting(s):
1999

About

Abstract

The FDA believed that Prandin was a very innovative drug that would provide the fast growing number of Americans suffering from type II diabetes with a better and more convenient treatment for their health problems. For this reason, the FDA was willing to put Prandin application on the fast track which would allow Novo Nordisk to have the product registered (thus making it legal to sell) in a maximum of 6 months. The decision to schedule the initial worldwide launch of Prandin / Novonorm in the United States in an extremely short time frame was not easy at all.

Settings

Location:
Industry:
Other setting(s):
1999

Related